|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 06-29 | Aclaris Therapeutics, Inc.(NasdaqGS:ACRS) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Aclaris Therapeutics, Inc.(NasdaqGS:ACRS) added to Russell 2500 Growth Benchmark | CI |
| Market Cap | 793M 693M 640M 590M 1.11B 76.39B 1.14B 7.65B 3.01B 37.42B 2.98B 2.91B 129B | P/E 2026 * |
-8.75x | P/E 2027 * | -7.13x |
|---|---|---|---|---|---|
| Enterprise Value | 658M 575M 530M 489M 921M 63.34B 942M 6.34B 2.49B 31.02B 2.47B 2.42B 107B | EV / Sales 2026 * |
115x | EV / Sales 2027 * | 125x |
| Free-Float |
97.72% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ACLS THER
| Manager | Title | Age | Since |
|---|---|---|---|
Neal Walker
CEO | Chief Executive Officer | 56 | 16/01/2024 |
Hugh Davis
PSD | President | 67 | 17/11/2024 |
Kevin Balthaser
DFI | Director of Finance/CFO | 39 | 31/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Walker
CHM | Chairman | 56 | 31/12/2022 |
Anand Mehra
BRD | Director/Board Member | 50 | 31/08/2014 |
| Director/Board Member | 59 | 31/08/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.24% | -1.54% | +52.85% | +71.85% | 53.83B | |
| -7.17% | -4.39% | +42.72% | +73.32% | 52.1B | |
| +0.80% | -6.31% | +5.62% | +417.78% | 23.48B | |
| -0.09% | -0.01% | -16.85% | -15.41% | 23.13B | |
| -5.95% | -2.58% | +29.53% | -9.47% | 19.36B | |
| -1.14% | +0.03% | +31.67% | -30.65% | 17.56B | |
| -5.16% | -7.00% | +168.44% | +314.96% | 15.2B | |
| -6.91% | -5.83% | +25.17% | +644.30% | 14.83B | |
| +0.43% | -1.03% | +25.75% | +189.74% | 14.06B | |
| Average | -2.77% | -2.62% | +40.54% | +184.05% | 25.95B | |
| Weighted average by Cap. | -2.80% | -2.36% | +39.55% | +143.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.71M 4.99M 4.61M 4.25M 8M 550M 8.18M 55.06M 21.66M 269M 21.45M 20.98M 928M | 5.36M 4.68M 4.32M 3.98M 7.51M 516M 7.67M 51.65M 20.31M 253M 20.12M 19.68M 870M |
| Net income | -84.78M -74.09M -68.37M -63.02M -119M -8.16B -121M -817M -321M -4B -318M -311M -13.77B | -103M -89.59M -82.67M -76.2M -144M -9.87B -147M -988M -389M -4.84B -385M -377M -16.64B |
| Net Debt | -136M -119M -109M -101M -190M -13.06B -194M -1.31B -514M -6.4B -509M -498M -22.02B | -125M -109M -101M -92.84M -175M -12.03B -179M -1.2B -474M -5.89B -469M -459M -20.28B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
